𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Secondary hemophagocytic syndrome in adults: a case series of 18 patients in a single institution and a review of literature

✍ Scribed by Munira Shabbir; John Lucas; John Lazarchick; Keisuke Shirai


Publisher
John Wiley and Sons
Year
2010
Tongue
English
Weight
457 KB
Volume
29
Category
Article
ISSN
0278-0232

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

Hemophagocytic lymphohistiocytosis (HLH) is rare in adults and is usually fatal without treatment. We present a consecutive series of 18 adults with HLH diagnosed at our institution between 2004 and 2009. All diagnoses were confirmed by pathology. The median age at diagnosis was 56 years (range: 18–73 years), with a male: female ratio of 2:1. Patients uniformly presented with fever. Fifty‐five per cent of the patients presented with evidence of hepatomegaly or splenomegaly. All of the patients had at least a bi‐ or trilineage cytopenia. Elevated liver enzymes, hyperferritinemia, hypertriglyceridemia and hyperfibrinogenemia were seen in 50, 100, 40 and 50% of patients, respectively. The presumed causes were as follows; haematological malignancies (n = 4), post‐autologous stem cell transplant (n = 2), infection (n = 2), rheumatologic illness (n = 2), sickle cell disease (n = 1), post‐orthotopic liver transplant (n = 1) and idiopathic (n = 3). The median time from suspicion to diagnosis was 5 days (1–27 days). Corticosteroids and/or cyclosporine were the most frequently used treatment regimen. Other agents used were etoposide, IVIG, cyclophosphamide and chemotherapy. The mortality rate was 72%, with multi‐system organ failure being the most common cause of death. Median survival time from diagnosis was 35 days. Six patients are alive to date. In a univariate analysis, the presence of fever was the only factor that was statistically significant for predicting a poor prognosis (early mortality) (p = 0.05). In conclusion, a high index of suspicion is the critical factor for early diagnosis. Early treatment with immunosuppressant is warranted, and a thorough diagnostic evaluation to identify the underlying cause should be undertaken. Copyright Β© 2010 John Wiley & Sons, Ltd.


πŸ“œ SIMILAR VOLUMES


Sacrococcygeal teratoma in adults : Case
✍ Elizabeth W. Ng; Pierluigi Porcu; Patrick J. Loehrer Sr. πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 189 KB πŸ‘ 2 views

## BACKGROUND. The sacrococcygeal area is the most frequent site of teratoma in infants, but it is a rare location for teratoma in adults. ## METHODS. The authors report two patients in their sixth decade of life with the pathologic diagnosis of sacrococcygeal teratoma. The clinical presentatio

Soft-tissue sarcomas of the head and nec
✍ Marco T. A. Figueiredo; Lourdes A. Marques; Nelson Campos-Filho πŸ“‚ Article πŸ“… 1988 πŸ› John Wiley and Sons 🌐 French βš– 273 KB πŸ‘ 1 views

Ninety-four soft-tissue sarcomas of head and neck occurring among 10,700 malignancies, seen during the period 1953-I980 in the head-and-neck surgical department, were studied with reference to age, sex, ethnic origin, site, histological type and survival. The objective was to review our own experien

Rhabdomyosarcoma in adults : A retrospec
✍ Andrea Ferrari; Palma Dileo; Michela Casanova; Rossella Bertulli; Cristina Meazz πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 English βš– 106 KB πŸ‘ 1 views

## Abstract ## BACKGROUND The goal of the current study was to clarify treatment outcomes for adult patients with rhabdomyosarcoma (RMS). Published series have reported definitively worse results for adults with RMS compared with children with RMS. This finding casts doubt on whether RMS is the sa

Langerhans' cell histiocytosis in adults
✍ Fiorina Giona; Roberta Caruso; Anna M. Testi; Maria L. Moleti; Francesco Malagni πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 English βš– 75 KB πŸ‘ 2 views

received VBL / HDMP; at last follow-up, 1 patient was in CCR 8 months after Biotechnology and Hematology, University ''La completion of therapy, and the other developed progressive disease 11 months Sapienza,'' Rome, Italy. later. The third patient was treated with interferon (IFN) and at last foll

Atypical findings in Kabuki syndrome: Re
✍ D. GeneviΓ¨ve; J. Amiel; G. Viot; M. Le Merrer; D. Sanlaville; A. Urtizberea; M. πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 English βš– 134 KB πŸ‘ 2 views

## Abstract Kabuki syndrome (KS) is a rare multiple congenital anomaly/mental retardation syndrome with an estimated frequency of 1/32,000 in Japan. Five major criteria delineate KS namely postnatal short stature, skeletal anomalies, moderate mental retardation, dermatoglyphic anomalies, and a char